Puberty clinical trials

Explore recruiting puberty clinical trials.

Recruiting puberty studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Puberty trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Towards a treatment for accelerated maturation in girls testing spiomet in a randomised placebo controlled, multicentre study.

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

The LIFE-MET Study: Lifestyle intervention and Metformin in early puberty. A randomized, placebo-controlled study on the effect of insulin sensitization and/or lifestyle intervention on pubertal progression.

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

A Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of Taldefgrobep Alfa in Ambulatory and Non-Ambulatory Participants with Spinal Muscular Atrophy with Open-Label Extension (RESILIENT)

Italy, Poland, Spain, Germany, Belgium, Czechia +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Klinefelter syndrome – the effect of Testosterone treatment In PubertY A randomized, double-blind placebo-controlled intervention study ‘The TiPY study’

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

An open-label study to collect safety and effectiveness information on long-term treatment with vamorolone in boys with Duchenne Muscular Dystrophy who have completed prior studies with vamorolone (The GUARDIAN Study)

Czechia, Spain, Belgium, Greece, Ireland, Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Efficacy and safety of a 4 year pubertal therapy with growth hormone (Omnitrope) or growth hormone and an aromatase inhibitor (Letrozole) in boys with a short predicted height.

Belgium

Therapeutic confirmatory (Phase III) EU CTIS Study details

Puberty trials by city

Puberty in Toronto Puberty in Vancouver Puberty in Montreal Puberty in Calgary Puberty in Edmonton Puberty in Ottawa Puberty in Winnipeg Puberty in Quebec City Puberty in Hamilton Puberty in Kitchener Puberty in London Puberty in Halifax Puberty in New York Puberty in Los Angeles Puberty in Chicago Puberty in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease